Global Health Product for Immune Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Health Product for Immune, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Health Product for Immune.
The Health Product for Immune market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Health Product for Immune market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Health Product for Immune manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Health Product for Immune manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Health Product for Immune in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Health Product for Immune market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Health Product for Immune market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Health Product for Immune manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Amway
- Suntory
- GNC
- INFINITUS
- Herbalife Nutrition
- USANA Health Sciences, Inc.
- PERFECT
- Nestlй SA
- H&H Group
- China New Era Group
- By-health
- Black Mores
- Glanbia Plc
- Nature’s
- Real Nutriceutical
- Capsule/Pills
- Powder
- Liquid
- Children/Teenagers
- Men
- Adults
- The Elderly
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Health Product for Immune manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Health Product for Immune in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 HEALTH PRODUCT FOR IMMUNE MARKET OVERVIEW
1.1 Product Overview and Scope of Health Product for Immune
1.2 Health Product for Immune Segment by Type
1.2.1 Global Health Product for Immune Market Value Comparison by Type (2023-2029)
1.2.2 Capsule/Pills
1.2.3 Powder
1.2.4 Liquid
1.3 Health Product for Immune Segment by Application
1.3.1 Global Health Product for Immune Market Value by Application: (2023-2029)
1.3.2 Children/Teenagers
1.3.3 Men
1.3.4 Adults
1.3.5 The Elderly
1.4 Global Health Product for Immune Market Size Estimates and Forecasts
1.4.1 Global Health Product for Immune Revenue 2018-2029
1.4.2 Global Health Product for Immune Sales 2018-2029
1.4.3 Global Health Product for Immune Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HEALTH PRODUCT FOR IMMUNE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Health Product for Immune Sales Market Share by Manufacturers (2018-2023)
2.2 Global Health Product for Immune Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Health Product for Immune Average Price by Manufacturers (2018-2023)
2.4 Global Health Product for Immune Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Health Product for Immune, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Health Product for Immune, Product Type & Application
2.7 Health Product for Immune Market Competitive Situation and Trends
2.7.1 Health Product for Immune Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Health Product for Immune Players Market Share by Revenue
2.7.3 Global Health Product for Immune Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HEALTH PRODUCT FOR IMMUNE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Health Product for Immune Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Health Product for Immune Global Health Product for Immune Sales by Region: 2018-2029
3.2.1 Global Health Product for Immune Sales by Region: 2018-2023
3.2.2 Global Health Product for Immune Sales by Region: 2024-2029
3.3 Global Health Product for Immune Global Health Product for Immune Revenue by Region: 2018-2029
3.3.1 Global Health Product for Immune Revenue by Region: 2018-2023
3.3.2 Global Health Product for Immune Revenue by Region: 2024-2029
3.4 North America Health Product for Immune Market Facts & Figures by Country
3.4.1 North America Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Health Product for Immune Sales by Country (2018-2029)
3.4.3 North America Health Product for Immune Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Health Product for Immune Market Facts & Figures by Country
3.5.1 Europe Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Health Product for Immune Sales by Country (2018-2029)
3.5.3 Europe Health Product for Immune Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Health Product for Immune Market Facts & Figures by Country
3.6.1 Asia Pacific Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Health Product for Immune Sales by Country (2018-2029)
3.6.3 Asia Pacific Health Product for Immune Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Health Product for Immune Market Facts & Figures by Country
3.7.1 Latin America Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Health Product for Immune Sales by Country (2018-2029)
3.7.3 Latin America Health Product for Immune Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Health Product for Immune Market Facts & Figures by Country
3.8.1 Middle East and Africa Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Health Product for Immune Sales by Country (2018-2029)
3.8.3 Middle East and Africa Health Product for Immune Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Health Product for Immune Sales by Type (2018-2029)
4.1.1 Global Health Product for Immune Sales by Type (2018-2023)
4.1.2 Global Health Product for Immune Sales by Type (2024-2029)
4.1.3 Global Health Product for Immune Sales Market Share by Type (2018-2029)
4.2 Global Health Product for Immune Revenue by Type (2018-2029)
4.2.1 Global Health Product for Immune Revenue by Type (2018-2023)
4.2.2 Global Health Product for Immune Revenue by Type (2024-2029)
4.2.3 Global Health Product for Immune Revenue Market Share by Type (2018-2029)
4.3 Global Health Product for Immune Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Health Product for Immune Sales by Application (2018-2029)
5.1.1 Global Health Product for Immune Sales by Application (2018-2023)
5.1.2 Global Health Product for Immune Sales by Application (2024-2029)
5.1.3 Global Health Product for Immune Sales Market Share by Application (2018-2029)
5.2 Global Health Product for Immune Revenue by Application (2018-2029)
5.2.1 Global Health Product for Immune Revenue by Application (2018-2023)
5.2.2 Global Health Product for Immune Revenue by Application (2024-2029)
5.2.3 Global Health Product for Immune Revenue Market Share by Application (2018-2029)
5.3 Global Health Product for Immune Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Amway
6.1.1 Amway Corporation Information
6.1.2 Amway Description and Business Overview
6.1.3 Amway Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amway Health Product for Immune Product Portfolio
6.1.5 Amway Recent Developments/Updates
6.2 Suntory
6.2.1 Suntory Corporation Information
6.2.2 Suntory Description and Business Overview
6.2.3 Suntory Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Suntory Health Product for Immune Product Portfolio
6.2.5 Suntory Recent Developments/Updates
6.3 GNC
6.3.1 GNC Corporation Information
6.3.2 GNC Description and Business Overview
6.3.3 GNC Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GNC Health Product for Immune Product Portfolio
6.3.5 GNC Recent Developments/Updates
6.4 INFINITUS
6.4.1 INFINITUS Corporation Information
6.4.2 INFINITUS Description and Business Overview
6.4.3 INFINITUS Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.4.4 INFINITUS Health Product for Immune Product Portfolio
6.4.5 INFINITUS Recent Developments/Updates
6.5 Herbalife Nutrition
6.5.1 Herbalife Nutrition Corporation Information
6.5.2 Herbalife Nutrition Description and Business Overview
6.5.3 Herbalife Nutrition Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Herbalife Nutrition Health Product for Immune Product Portfolio
6.5.5 Herbalife Nutrition Recent Developments/Updates
6.6 USANA Health Sciences, Inc.
6.6.1 USANA Health Sciences, Inc. Corporation Information
6.6.2 USANA Health Sciences, Inc. Description and Business Overview
6.6.3 USANA Health Sciences, Inc. Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.6.4 USANA Health Sciences, Inc. Health Product for Immune Product Portfolio
6.6.5 USANA Health Sciences, Inc. Recent Developments/Updates
6.7 PERFECT
6.6.1 PERFECT Corporation Information
6.6.2 PERFECT Description and Business Overview
6.6.3 PERFECT Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PERFECT Health Product for Immune Product Portfolio
6.7.5 PERFECT Recent Developments/Updates
6.8 Nestlй SA
6.8.1 Nestlй SA Corporation Information
6.8.2 Nestlй SA Description and Business Overview
6.8.3 Nestlй SA Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nestlй SA Health Product for Immune Product Portfolio
6.8.5 Nestlй SA Recent Developments/Updates
6.9 H&H Group
6.9.1 H&H Group Corporation Information
6.9.2 H&H Group Description and Business Overview
6.9.3 H&H Group Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.9.4 H&H Group Health Product for Immune Product Portfolio
6.9.5 H&H Group Recent Developments/Updates
6.10 China New Era Group
6.10.1 China New Era Group Corporation Information
6.10.2 China New Era Group Description and Business Overview
6.10.3 China New Era Group Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.10.4 China New Era Group Health Product for Immune Product Portfolio
6.10.5 China New Era Group Recent Developments/Updates
6.11 By-health
6.11.1 By-health Corporation Information
6.11.2 By-health Health Product for Immune Description and Business Overview
6.11.3 By-health Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.11.4 By-health Health Product for Immune Product Portfolio
6.11.5 By-health Recent Developments/Updates
6.12 Black Mores
6.12.1 Black Mores Corporation Information
6.12.2 Black Mores Health Product for Immune Description and Business Overview
6.12.3 Black Mores Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Black Mores Health Product for Immune Product Portfolio
6.12.5 Black Mores Recent Developments/Updates
6.13 Glanbia Plc
6.13.1 Glanbia Plc Corporation Information
6.13.2 Glanbia Plc Health Product for Immune Description and Business Overview
6.13.3 Glanbia Plc Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Glanbia Plc Health Product for Immune Product Portfolio
6.13.5 Glanbia Plc Recent Developments/Updates
6.14 Nature’s
6.14.1 Nature’s Corporation Information
6.14.2 Nature’s Health Product for Immune Description and Business Overview
6.14.3 Nature’s Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nature’s Health Product for Immune Product Portfolio
6.14.5 Nature’s Recent Developments/Updates
6.15 Real Nutriceutical
6.15.1 Real Nutriceutical Corporation Information
6.15.2 Real Nutriceutical Health Product for Immune Description and Business Overview
6.15.3 Real Nutriceutical Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Real Nutriceutical Health Product for Immune Product Portfolio
6.15.5 Real Nutriceutical Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Health Product for Immune Industry Chain Analysis
7.2 Health Product for Immune Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Health Product for Immune Production Mode & Process
7.4 Health Product for Immune Sales and Marketing
7.4.1 Health Product for Immune Sales Channels
7.4.2 Health Product for Immune Distributors
7.5 Health Product for Immune Customers
8 HEALTH PRODUCT FOR IMMUNE MARKET DYNAMICS
8.1 Health Product for Immune Industry Trends
8.2 Health Product for Immune Market Drivers
8.3 Health Product for Immune Market Challenges
8.4 Health Product for Immune Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Health Product for Immune
1.2 Health Product for Immune Segment by Type
1.2.1 Global Health Product for Immune Market Value Comparison by Type (2023-2029)
1.2.2 Capsule/Pills
1.2.3 Powder
1.2.4 Liquid
1.3 Health Product for Immune Segment by Application
1.3.1 Global Health Product for Immune Market Value by Application: (2023-2029)
1.3.2 Children/Teenagers
1.3.3 Men
1.3.4 Adults
1.3.5 The Elderly
1.4 Global Health Product for Immune Market Size Estimates and Forecasts
1.4.1 Global Health Product for Immune Revenue 2018-2029
1.4.2 Global Health Product for Immune Sales 2018-2029
1.4.3 Global Health Product for Immune Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 HEALTH PRODUCT FOR IMMUNE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Health Product for Immune Sales Market Share by Manufacturers (2018-2023)
2.2 Global Health Product for Immune Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Health Product for Immune Average Price by Manufacturers (2018-2023)
2.4 Global Health Product for Immune Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Health Product for Immune, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Health Product for Immune, Product Type & Application
2.7 Health Product for Immune Market Competitive Situation and Trends
2.7.1 Health Product for Immune Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Health Product for Immune Players Market Share by Revenue
2.7.3 Global Health Product for Immune Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HEALTH PRODUCT FOR IMMUNE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Health Product for Immune Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Health Product for Immune Global Health Product for Immune Sales by Region: 2018-2029
3.2.1 Global Health Product for Immune Sales by Region: 2018-2023
3.2.2 Global Health Product for Immune Sales by Region: 2024-2029
3.3 Global Health Product for Immune Global Health Product for Immune Revenue by Region: 2018-2029
3.3.1 Global Health Product for Immune Revenue by Region: 2018-2023
3.3.2 Global Health Product for Immune Revenue by Region: 2024-2029
3.4 North America Health Product for Immune Market Facts & Figures by Country
3.4.1 North America Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Health Product for Immune Sales by Country (2018-2029)
3.4.3 North America Health Product for Immune Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Health Product for Immune Market Facts & Figures by Country
3.5.1 Europe Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Health Product for Immune Sales by Country (2018-2029)
3.5.3 Europe Health Product for Immune Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Health Product for Immune Market Facts & Figures by Country
3.6.1 Asia Pacific Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Health Product for Immune Sales by Country (2018-2029)
3.6.3 Asia Pacific Health Product for Immune Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Health Product for Immune Market Facts & Figures by Country
3.7.1 Latin America Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Health Product for Immune Sales by Country (2018-2029)
3.7.3 Latin America Health Product for Immune Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Health Product for Immune Market Facts & Figures by Country
3.8.1 Middle East and Africa Health Product for Immune Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Health Product for Immune Sales by Country (2018-2029)
3.8.3 Middle East and Africa Health Product for Immune Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Health Product for Immune Sales by Type (2018-2029)
4.1.1 Global Health Product for Immune Sales by Type (2018-2023)
4.1.2 Global Health Product for Immune Sales by Type (2024-2029)
4.1.3 Global Health Product for Immune Sales Market Share by Type (2018-2029)
4.2 Global Health Product for Immune Revenue by Type (2018-2029)
4.2.1 Global Health Product for Immune Revenue by Type (2018-2023)
4.2.2 Global Health Product for Immune Revenue by Type (2024-2029)
4.2.3 Global Health Product for Immune Revenue Market Share by Type (2018-2029)
4.3 Global Health Product for Immune Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Health Product for Immune Sales by Application (2018-2029)
5.1.1 Global Health Product for Immune Sales by Application (2018-2023)
5.1.2 Global Health Product for Immune Sales by Application (2024-2029)
5.1.3 Global Health Product for Immune Sales Market Share by Application (2018-2029)
5.2 Global Health Product for Immune Revenue by Application (2018-2029)
5.2.1 Global Health Product for Immune Revenue by Application (2018-2023)
5.2.2 Global Health Product for Immune Revenue by Application (2024-2029)
5.2.3 Global Health Product for Immune Revenue Market Share by Application (2018-2029)
5.3 Global Health Product for Immune Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Amway
6.1.1 Amway Corporation Information
6.1.2 Amway Description and Business Overview
6.1.3 Amway Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amway Health Product for Immune Product Portfolio
6.1.5 Amway Recent Developments/Updates
6.2 Suntory
6.2.1 Suntory Corporation Information
6.2.2 Suntory Description and Business Overview
6.2.3 Suntory Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Suntory Health Product for Immune Product Portfolio
6.2.5 Suntory Recent Developments/Updates
6.3 GNC
6.3.1 GNC Corporation Information
6.3.2 GNC Description and Business Overview
6.3.3 GNC Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GNC Health Product for Immune Product Portfolio
6.3.5 GNC Recent Developments/Updates
6.4 INFINITUS
6.4.1 INFINITUS Corporation Information
6.4.2 INFINITUS Description and Business Overview
6.4.3 INFINITUS Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.4.4 INFINITUS Health Product for Immune Product Portfolio
6.4.5 INFINITUS Recent Developments/Updates
6.5 Herbalife Nutrition
6.5.1 Herbalife Nutrition Corporation Information
6.5.2 Herbalife Nutrition Description and Business Overview
6.5.3 Herbalife Nutrition Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Herbalife Nutrition Health Product for Immune Product Portfolio
6.5.5 Herbalife Nutrition Recent Developments/Updates
6.6 USANA Health Sciences, Inc.
6.6.1 USANA Health Sciences, Inc. Corporation Information
6.6.2 USANA Health Sciences, Inc. Description and Business Overview
6.6.3 USANA Health Sciences, Inc. Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.6.4 USANA Health Sciences, Inc. Health Product for Immune Product Portfolio
6.6.5 USANA Health Sciences, Inc. Recent Developments/Updates
6.7 PERFECT
6.6.1 PERFECT Corporation Information
6.6.2 PERFECT Description and Business Overview
6.6.3 PERFECT Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PERFECT Health Product for Immune Product Portfolio
6.7.5 PERFECT Recent Developments/Updates
6.8 Nestlй SA
6.8.1 Nestlй SA Corporation Information
6.8.2 Nestlй SA Description and Business Overview
6.8.3 Nestlй SA Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nestlй SA Health Product for Immune Product Portfolio
6.8.5 Nestlй SA Recent Developments/Updates
6.9 H&H Group
6.9.1 H&H Group Corporation Information
6.9.2 H&H Group Description and Business Overview
6.9.3 H&H Group Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.9.4 H&H Group Health Product for Immune Product Portfolio
6.9.5 H&H Group Recent Developments/Updates
6.10 China New Era Group
6.10.1 China New Era Group Corporation Information
6.10.2 China New Era Group Description and Business Overview
6.10.3 China New Era Group Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.10.4 China New Era Group Health Product for Immune Product Portfolio
6.10.5 China New Era Group Recent Developments/Updates
6.11 By-health
6.11.1 By-health Corporation Information
6.11.2 By-health Health Product for Immune Description and Business Overview
6.11.3 By-health Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.11.4 By-health Health Product for Immune Product Portfolio
6.11.5 By-health Recent Developments/Updates
6.12 Black Mores
6.12.1 Black Mores Corporation Information
6.12.2 Black Mores Health Product for Immune Description and Business Overview
6.12.3 Black Mores Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Black Mores Health Product for Immune Product Portfolio
6.12.5 Black Mores Recent Developments/Updates
6.13 Glanbia Plc
6.13.1 Glanbia Plc Corporation Information
6.13.2 Glanbia Plc Health Product for Immune Description and Business Overview
6.13.3 Glanbia Plc Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Glanbia Plc Health Product for Immune Product Portfolio
6.13.5 Glanbia Plc Recent Developments/Updates
6.14 Nature’s
6.14.1 Nature’s Corporation Information
6.14.2 Nature’s Health Product for Immune Description and Business Overview
6.14.3 Nature’s Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nature’s Health Product for Immune Product Portfolio
6.14.5 Nature’s Recent Developments/Updates
6.15 Real Nutriceutical
6.15.1 Real Nutriceutical Corporation Information
6.15.2 Real Nutriceutical Health Product for Immune Description and Business Overview
6.15.3 Real Nutriceutical Health Product for Immune Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Real Nutriceutical Health Product for Immune Product Portfolio
6.15.5 Real Nutriceutical Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Health Product for Immune Industry Chain Analysis
7.2 Health Product for Immune Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Health Product for Immune Production Mode & Process
7.4 Health Product for Immune Sales and Marketing
7.4.1 Health Product for Immune Sales Channels
7.4.2 Health Product for Immune Distributors
7.5 Health Product for Immune Customers
8 HEALTH PRODUCT FOR IMMUNE MARKET DYNAMICS
8.1 Health Product for Immune Industry Trends
8.2 Health Product for Immune Market Drivers
8.3 Health Product for Immune Market Challenges
8.4 Health Product for Immune Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Health Product for Immune Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Health Product for Immune Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Health Product for Immune Market Competitive Situation by Manufacturers in 2022
Table 4. Global Health Product for Immune Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Health Product for Immune Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Health Product for Immune Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Health Product for Immune Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Health Product for Immune Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Health Product for Immune, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Health Product for Immune, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Health Product for Immune, Product Type & Application
Table 12. Global Key Manufacturers of Health Product for Immune, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Health Product for Immune by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Health Product for Immune as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Health Product for Immune Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Health Product for Immune Sales by Region (2018-2023) & (K Units)
Table 18. Global Health Product for Immune Sales Market Share by Region (2018-2023)
Table 19. Global Health Product for Immune Sales by Region (2024-2029) & (K Units)
Table 20. Global Health Product for Immune Sales Market Share by Region (2024-2029)
Table 21. Global Health Product for Immune Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Health Product for Immune Revenue Market Share by Region (2018-2023)
Table 23. Global Health Product for Immune Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Health Product for Immune Revenue Market Share by Region (2024-2029)
Table 25. North America Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 27. North America Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 28. North America Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 32. Europe Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 33. Europe Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Health Product for Immune Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Health Product for Immune Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Health Product for Immune Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Health Product for Immune Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Health Product for Immune Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Health Product for Immune Sales (K Units) by Type (2018-2023)
Table 51. Global Health Product for Immune Sales (K Units) by Type (2024-2029)
Table 52. Global Health Product for Immune Sales Market Share by Type (2018-2023)
Table 53. Global Health Product for Immune Sales Market Share by Type (2024-2029)
Table 54. Global Health Product for Immune Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Health Product for Immune Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Health Product for Immune Revenue Market Share by Type (2018-2023)
Table 57. Global Health Product for Immune Revenue Market Share by Type (2024-2029)
Table 58. Global Health Product for Immune Price (US$/Unit) by Type (2018-2023)
Table 59. Global Health Product for Immune Price (US$/Unit) by Type (2024-2029)
Table 60. Global Health Product for Immune Sales (K Units) by Application (2018-2023)
Table 61. Global Health Product for Immune Sales (K Units) by Application (2024-2029)
Table 62. Global Health Product for Immune Sales Market Share by Application (2018-2023)
Table 63. Global Health Product for Immune Sales Market Share by Application (2024-2029)
Table 64. Global Health Product for Immune Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Health Product for Immune Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Health Product for Immune Revenue Market Share by Application (2018-2023)
Table 67. Global Health Product for Immune Revenue Market Share by Application (2024-2029)
Table 68. Global Health Product for Immune Price (US$/Unit) by Application (2018-2023)
Table 69. Global Health Product for Immune Price (US$/Unit) by Application (2024-2029)
Table 70. Amway Corporation Information
Table 71. Amway Description and Business Overview
Table 72. Amway Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Amway Health Product for Immune Product
Table 74. Amway Recent Developments/Updates
Table 75. Suntory Corporation Information
Table 76. Suntory Description and Business Overview
Table 77. Suntory Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Suntory Health Product for Immune Product
Table 79. Suntory Recent Developments/Updates
Table 80. GNC Corporation Information
Table 81. GNC Description and Business Overview
Table 82. GNC Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GNC Health Product for Immune Product
Table 84. GNC Recent Developments/Updates
Table 85. INFINITUS Corporation Information
Table 86. INFINITUS Description and Business Overview
Table 87. INFINITUS Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. INFINITUS Health Product for Immune Product
Table 89. INFINITUS Recent Developments/Updates
Table 90. Herbalife Nutrition Corporation Information
Table 91. Herbalife Nutrition Description and Business Overview
Table 92. Herbalife Nutrition Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Herbalife Nutrition Health Product for Immune Product
Table 94. Herbalife Nutrition Recent Developments/Updates
Table 95. USANA Health Sciences, Inc. Corporation Information
Table 96. USANA Health Sciences, Inc. Description and Business Overview
Table 97. USANA Health Sciences, Inc. Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. USANA Health Sciences, Inc. Health Product for Immune Product
Table 99. USANA Health Sciences, Inc. Recent Developments/Updates
Table 100. PERFECT Corporation Information
Table 101. PERFECT Description and Business Overview
Table 102. PERFECT Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. PERFECT Health Product for Immune Product
Table 104. PERFECT Recent Developments/Updates
Table 105. Nestlй SA Corporation Information
Table 106. Nestlй SA Description and Business Overview
Table 107. Nestlй SA Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Nestlй SA Health Product for Immune Product
Table 109. Nestlй SA Recent Developments/Updates
Table 110. H&H Group Corporation Information
Table 111. H&H Group Description and Business Overview
Table 112. H&H Group Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. H&H Group Health Product for Immune Product
Table 114. H&H Group Recent Developments/Updates
Table 115. China New Era Group Corporation Information
Table 116. China New Era Group Description and Business Overview
Table 117. China New Era Group Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. China New Era Group Health Product for Immune Product
Table 119. China New Era Group Recent Developments/Updates
Table 120. By-health Corporation Information
Table 121. By-health Description and Business Overview
Table 122. By-health Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. By-health Health Product for Immune Product
Table 124. By-health Recent Developments/Updates
Table 125. Black Mores Corporation Information
Table 126. Black Mores Description and Business Overview
Table 127. Black Mores Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Black Mores Health Product for Immune Product
Table 129. Black Mores Recent Developments/Updates
Table 130. Glanbia Plc Corporation Information
Table 131. Glanbia Plc Description and Business Overview
Table 132. Glanbia Plc Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Glanbia Plc Health Product for Immune Product
Table 134. Glanbia Plc Recent Developments/Updates
Table 135. Nature’s Corporation Information
Table 136. Nature’s Description and Business Overview
Table 137. Nature’s Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Nature’s Health Product for Immune Product
Table 139. Nature’s Recent Developments/Updates
Table 140. Real Nutriceutical Corporation Information
Table 141. Real Nutriceutical Description and Business Overview
Table 142. Real Nutriceutical Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Real Nutriceutical Health Product for Immune Product
Table 144. Real Nutriceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Health Product for Immune Distributors List
Table 148. Health Product for Immune Customers List
Table 149. Health Product for Immune Market Trends
Table 150. Health Product for Immune Market Drivers
Table 151. Health Product for Immune Market Challenges
Table 152. Health Product for Immune Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 1. Global Health Product for Immune Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Health Product for Immune Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Health Product for Immune Market Competitive Situation by Manufacturers in 2022
Table 4. Global Health Product for Immune Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Health Product for Immune Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Health Product for Immune Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Health Product for Immune Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Health Product for Immune Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Health Product for Immune, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Health Product for Immune, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Health Product for Immune, Product Type & Application
Table 12. Global Key Manufacturers of Health Product for Immune, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Health Product for Immune by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Health Product for Immune as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Health Product for Immune Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Health Product for Immune Sales by Region (2018-2023) & (K Units)
Table 18. Global Health Product for Immune Sales Market Share by Region (2018-2023)
Table 19. Global Health Product for Immune Sales by Region (2024-2029) & (K Units)
Table 20. Global Health Product for Immune Sales Market Share by Region (2024-2029)
Table 21. Global Health Product for Immune Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Health Product for Immune Revenue Market Share by Region (2018-2023)
Table 23. Global Health Product for Immune Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Health Product for Immune Revenue Market Share by Region (2024-2029)
Table 25. North America Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 27. North America Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 28. North America Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 32. Europe Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 33. Europe Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Health Product for Immune Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Health Product for Immune Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Health Product for Immune Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Health Product for Immune Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Health Product for Immune Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Health Product for Immune Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Health Product for Immune Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Health Product for Immune Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Health Product for Immune Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Health Product for Immune Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Health Product for Immune Sales (K Units) by Type (2018-2023)
Table 51. Global Health Product for Immune Sales (K Units) by Type (2024-2029)
Table 52. Global Health Product for Immune Sales Market Share by Type (2018-2023)
Table 53. Global Health Product for Immune Sales Market Share by Type (2024-2029)
Table 54. Global Health Product for Immune Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Health Product for Immune Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Health Product for Immune Revenue Market Share by Type (2018-2023)
Table 57. Global Health Product for Immune Revenue Market Share by Type (2024-2029)
Table 58. Global Health Product for Immune Price (US$/Unit) by Type (2018-2023)
Table 59. Global Health Product for Immune Price (US$/Unit) by Type (2024-2029)
Table 60. Global Health Product for Immune Sales (K Units) by Application (2018-2023)
Table 61. Global Health Product for Immune Sales (K Units) by Application (2024-2029)
Table 62. Global Health Product for Immune Sales Market Share by Application (2018-2023)
Table 63. Global Health Product for Immune Sales Market Share by Application (2024-2029)
Table 64. Global Health Product for Immune Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Health Product for Immune Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Health Product for Immune Revenue Market Share by Application (2018-2023)
Table 67. Global Health Product for Immune Revenue Market Share by Application (2024-2029)
Table 68. Global Health Product for Immune Price (US$/Unit) by Application (2018-2023)
Table 69. Global Health Product for Immune Price (US$/Unit) by Application (2024-2029)
Table 70. Amway Corporation Information
Table 71. Amway Description and Business Overview
Table 72. Amway Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Amway Health Product for Immune Product
Table 74. Amway Recent Developments/Updates
Table 75. Suntory Corporation Information
Table 76. Suntory Description and Business Overview
Table 77. Suntory Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Suntory Health Product for Immune Product
Table 79. Suntory Recent Developments/Updates
Table 80. GNC Corporation Information
Table 81. GNC Description and Business Overview
Table 82. GNC Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GNC Health Product for Immune Product
Table 84. GNC Recent Developments/Updates
Table 85. INFINITUS Corporation Information
Table 86. INFINITUS Description and Business Overview
Table 87. INFINITUS Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. INFINITUS Health Product for Immune Product
Table 89. INFINITUS Recent Developments/Updates
Table 90. Herbalife Nutrition Corporation Information
Table 91. Herbalife Nutrition Description and Business Overview
Table 92. Herbalife Nutrition Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Herbalife Nutrition Health Product for Immune Product
Table 94. Herbalife Nutrition Recent Developments/Updates
Table 95. USANA Health Sciences, Inc. Corporation Information
Table 96. USANA Health Sciences, Inc. Description and Business Overview
Table 97. USANA Health Sciences, Inc. Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. USANA Health Sciences, Inc. Health Product for Immune Product
Table 99. USANA Health Sciences, Inc. Recent Developments/Updates
Table 100. PERFECT Corporation Information
Table 101. PERFECT Description and Business Overview
Table 102. PERFECT Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. PERFECT Health Product for Immune Product
Table 104. PERFECT Recent Developments/Updates
Table 105. Nestlй SA Corporation Information
Table 106. Nestlй SA Description and Business Overview
Table 107. Nestlй SA Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Nestlй SA Health Product for Immune Product
Table 109. Nestlй SA Recent Developments/Updates
Table 110. H&H Group Corporation Information
Table 111. H&H Group Description and Business Overview
Table 112. H&H Group Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. H&H Group Health Product for Immune Product
Table 114. H&H Group Recent Developments/Updates
Table 115. China New Era Group Corporation Information
Table 116. China New Era Group Description and Business Overview
Table 117. China New Era Group Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. China New Era Group Health Product for Immune Product
Table 119. China New Era Group Recent Developments/Updates
Table 120. By-health Corporation Information
Table 121. By-health Description and Business Overview
Table 122. By-health Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. By-health Health Product for Immune Product
Table 124. By-health Recent Developments/Updates
Table 125. Black Mores Corporation Information
Table 126. Black Mores Description and Business Overview
Table 127. Black Mores Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Black Mores Health Product for Immune Product
Table 129. Black Mores Recent Developments/Updates
Table 130. Glanbia Plc Corporation Information
Table 131. Glanbia Plc Description and Business Overview
Table 132. Glanbia Plc Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Glanbia Plc Health Product for Immune Product
Table 134. Glanbia Plc Recent Developments/Updates
Table 135. Nature’s Corporation Information
Table 136. Nature’s Description and Business Overview
Table 137. Nature’s Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Nature’s Health Product for Immune Product
Table 139. Nature’s Recent Developments/Updates
Table 140. Real Nutriceutical Corporation Information
Table 141. Real Nutriceutical Description and Business Overview
Table 142. Real Nutriceutical Health Product for Immune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Real Nutriceutical Health Product for Immune Product
Table 144. Real Nutriceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Health Product for Immune Distributors List
Table 148. Health Product for Immune Customers List
Table 149. Health Product for Immune Market Trends
Table 150. Health Product for Immune Market Drivers
Table 151. Health Product for Immune Market Challenges
Table 152. Health Product for Immune Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Health Product for Immune
Figure 2. Global Health Product for Immune Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Health Product for Immune Market Share by Type in 2022 & 2029
Figure 4. Capsule/Pills Product Picture
Figure 5. Powder Product Picture
Figure 6. Liquid Product Picture
Figure 7. Global Health Product for Immune Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Health Product for Immune Market Share by Application in 2022 & 2029
Figure 9. Children/Teenagers
Figure 10. Men
Figure 11. Adults
Figure 12. The Elderly
Figure 13. Global Health Product for Immune Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Health Product for Immune Market Size (2018-2029) & (US$ Million)
Figure 15. Global Health Product for Immune Sales (2018-2029) & (K Units)
Figure 16. Global Health Product for Immune Average Price (US$/Unit) & (2018-2029)
Figure 17. Health Product for Immune Report Years Considered
Figure 18. Health Product for Immune Sales Share by Manufacturers in 2022
Figure 19. Global Health Product for Immune Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Health Product for Immune Players: Market Share by Revenue in 2022
Figure 21. Health Product for Immune Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Health Product for Immune Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 24. North America Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 25. United States Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 28. Europe Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 29. Germany Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Health Product for Immune Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Health Product for Immune Revenue Market Share by Region (2018-2029)
Figure 36. China Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 44. Latin America Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Health Product for Immune by Type (2018-2029)
Figure 54. Global Revenue Market Share of Health Product for Immune by Type (2018-2029)
Figure 55. Global Health Product for Immune Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Health Product for Immune by Application (2018-2029)
Figure 57. Global Revenue Market Share of Health Product for Immune by Application (2018-2029)
Figure 58. Global Health Product for Immune Price (US$/Unit) by Application (2018-2029)
Figure 59. Health Product for Immune Value Chain
Figure 60. Health Product for Immune Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of Health Product for Immune
Figure 2. Global Health Product for Immune Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Health Product for Immune Market Share by Type in 2022 & 2029
Figure 4. Capsule/Pills Product Picture
Figure 5. Powder Product Picture
Figure 6. Liquid Product Picture
Figure 7. Global Health Product for Immune Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Health Product for Immune Market Share by Application in 2022 & 2029
Figure 9. Children/Teenagers
Figure 10. Men
Figure 11. Adults
Figure 12. The Elderly
Figure 13. Global Health Product for Immune Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Health Product for Immune Market Size (2018-2029) & (US$ Million)
Figure 15. Global Health Product for Immune Sales (2018-2029) & (K Units)
Figure 16. Global Health Product for Immune Average Price (US$/Unit) & (2018-2029)
Figure 17. Health Product for Immune Report Years Considered
Figure 18. Health Product for Immune Sales Share by Manufacturers in 2022
Figure 19. Global Health Product for Immune Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Health Product for Immune Players: Market Share by Revenue in 2022
Figure 21. Health Product for Immune Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Health Product for Immune Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 24. North America Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 25. United States Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 28. Europe Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 29. Germany Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Health Product for Immune Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Health Product for Immune Revenue Market Share by Region (2018-2029)
Figure 36. China Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 44. Latin America Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Health Product for Immune Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Health Product for Immune Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Health Product for Immune Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Health Product for Immune by Type (2018-2029)
Figure 54. Global Revenue Market Share of Health Product for Immune by Type (2018-2029)
Figure 55. Global Health Product for Immune Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Health Product for Immune by Application (2018-2029)
Figure 57. Global Revenue Market Share of Health Product for Immune by Application (2018-2029)
Figure 58. Global Health Product for Immune Price (US$/Unit) by Application (2018-2029)
Figure 59. Health Product for Immune Value Chain
Figure 60. Health Product for Immune Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
